KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) EPS (Basic): 2009-2024

Historic EPS (Basic) for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to -$3.60.

  • Emergent BioSolutions' EPS (Basic) fell 55.56% to $0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.42, marking a year-over-year increase of 136.13%. This contributed to the annual value of -$3.60 for FY2024, which is 75.76% up from last year.
  • Emergent BioSolutions' EPS (Basic) amounted to -$3.60 in FY2024, which was up 75.76% from -$14.85 recorded in FY2023.
  • Emergent BioSolutions' 5-year EPS (Basic) high stood at $5.80 for FY2020, and its period low was -$14.85 during FY2023.
  • For the 3-year period, Emergent BioSolutions' EPS (Basic) averaged around -$7.56, with its median value being -$4.22 (2022).
  • Per our database at Business Quant, Emergent BioSolutions' EPS (Basic) soared by 447.17% in 2020 and then crashed by 251.90% in 2023.
  • Emergent BioSolutions' EPS (Basic) (Yearly) stood at $5.80 in 2020, then declined by 29.31% to $4.10 in 2021, then crashed by 202.93% to -$4.22 in 2022, then crashed by 251.90% to -$14.85 in 2023, then soared by 75.76% to -$3.60 in 2024.